PB
Propel Bio Management, LLC disclosed a 10.1% stake in MIST
Propel Bio Management, LLC reported owning 10.1% of Milestone Pharmaceuticals Inc. (MIST) (12,615,010 shares) in a Schedule 13G filed Nov 20, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 20, 2026
- Source
- Schedule 13G